JAK-STAT signaling is highly active in CSCs, and studies have reported that activation of STAT-3 by IL-6 has a profound effect on tumor initiation and progression, invasion and metastasis by protecting tumor cells from apoptosis, driving epithelial–mesenchymal plasticity, and enhancing angiogenesis (86, 88, 89). This evidence concerns the gene IL6 and neoplasm.